speb/financial-data huggingface dataset:
CRIS income_statement (annual, 2024-12-31) — +Total Revenue: 10908000.00
CRIS balance_sheet (annual, 2024-12-31) — Accounts Payable: 3024000.00
CRIS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 3349000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 3349000.00
CRIS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1013000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1013000.00
CRIS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1233716000.00
CRIS cash_flow (annual, 2024-12-31) — Amortization Of Securities: -16000.00
CRIS cash_flow (quarterly, 2024-12-31) — Amortization Of Securities: 428000.00
CRIS income_statement (annual, 2024-12-31) — Basic Average Shares: 315314.00
CRIS income_statement (annual, 2024-12-31) — Basic EPS: -137.60
CRIS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 27225000.00
CRIS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 2954000.00
CRIS balance_sheet (annual, 2024-12-31) — Capital Stock: 85000.00
CRIS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 19997000.00
CRIS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 19997000.00
CRIS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 3437000.00
CRIS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 29442000.00
CRIS cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -428000.00
CRIS cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -39563000.00
CRIS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1223000.00
CRIS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -2077000.00
CRIS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 139000.00
CRIS cash_flow (annual, 2024-12-31) — Change In Receivables: -555000.00
CRIS cash_flow (annual, 2024-12-31) — Change In Working Capital: -3716000.00
CRIS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -555000.00
CRIS cash_flow (annual, 2024-12-31) — Changes In Cash: -6684000.00
CRIS balance_sheet (annual, 2024-12-31) — Common Stock: 85000.00
CRIS balance_sheet (annual, 2024-12-31) — Common Stock Equity: -5998000.00
CRIS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 12023000.00
CRIS income_statement (annual, 2024-12-31) — Cost Of Revenue: 98000.00
CRIS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 7111000.00
CRIS balance_sheet (annual, 2024-12-31) — Current Assets: 26385000.00
CRIS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 1336000.00
CRIS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 1336000.00
CRIS balance_sheet (annual, 2024-12-31) — Current Liabilities: 19027000.00
CRIS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 203000.00
CRIS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 203000.00
CRIS income_statement (annual, 2024-12-31) — Diluted Average Shares: 315314.00
CRIS income_statement (annual, 2024-12-31) — Diluted EPS: -137.60
CRIS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -43389000.00
CRIS income_statement (annual, 2024-12-31) — EBIT: -42774000.00
CRIS income_statement (annual, 2024-12-31) — EBITDA: -42571000.00
CRIS cash_flow (annual, 2024-12-31) — End Cash Position: 20541000.00
CRIS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3437000.00
CRIS cash_flow (annual, 2024-12-31) — Free Cash Flow: -39563000.00
CRIS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CRIS balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CRIS income_statement (annual, 2024-12-31) — General And Administrative Expense: 16790000.00
CRIS balance_sheet (annual, 2024-12-31) — Goodwill: 8982000.00
CRIS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (annual, 2024-12-31) — Gross PPE: 4407000.00
CRIS income_statement (annual, 2024-12-31) — Gross Profit: 10810000.00
CRIS income_statement (annual, 2024-12-31) — Insurance And Claims: 904000.00
CRIS income_statement (annual, 2024-12-31) — Interest Expense: 615000.00
CRIS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 615000.00
CRIS income_statement (annual, 2024-12-31) — Interest Income: 1768000.00
CRIS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1768000.00
CRIS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 461000.00
CRIS balance_sheet (annual, 2024-12-31) — Invested Capital: -5998000.00
CRIS cash_flow (annual, 2024-12-31) — Investing Cash Flow: 29442000.00
CRIS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 12023000.00
CRIS balance_sheet (annual, 2024-12-31) — Leases: 257000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Leases: 257000.00
CRIS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1618000.00
CRIS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1618000.00
CRIS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 987000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 987000.00
CRIS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CRIS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 12023000.00
CRIS income_statement (annual, 2024-12-31) — Net Income: -43389000.00
CRIS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -43389000.00
CRIS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -43389000.00
CRIS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -43389000.00
CRIS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -43389000.00
CRIS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -43389000.00
CRIS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -43389000.00
CRIS income_statement (annual, 2024-12-31) — Net Interest Income: 1153000.00
CRIS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 29442000.00
CRIS cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: -428000.00
CRIS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1153000.00
CRIS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -8586000.00
CRIS cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -2205000.00
CRIS balance_sheet (annual, 2024-12-31) — Net PPE: 3394000.00
CRIS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -14980000.00
CRIS income_statement (annual, 2024-12-31) — Normalized EBITDA: -42571000.00
CRIS income_statement (annual, 2024-12-31) — Normalized Income: -43389000.00
CRIS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -39563000.00
CRIS income_statement (annual, 2024-12-31) — Operating Income: -44542000.00
CRIS income_statement (annual, 2024-12-31) — Operating Revenue: 10908000.00
CRIS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 424390.00
CRIS balance_sheet (annual, 2024-12-31) — Other Current Assets: 3039000.00
CRIS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 7556000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 7556000.00
CRIS income_statement (annual, 2024-12-31) — Other Gand A: 7164000.00
CRIS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1428000.00
CRIS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2504000.00
CRIS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 26618000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 26618000.00
CRIS balance_sheet (annual, 2024-12-31) — Other Properties: 3163000.00
CRIS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
CRIS balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
CRIS balance_sheet (annual, 2024-12-31) — Payables: 3024000.00
CRIS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 10135000.00
CRIS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CRIS income_statement (annual, 2024-12-31) — Pretax Income: -43389000.00
CRIS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRIS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CRIS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -18098000.00
CRIS cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
CRIS balance_sheet (annual, 2024-12-31) — Receivables: 3349000.00
CRIS balance_sheet (quarterly, 2024-12-31) — Receivables: 3349000.00
CRIS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 98000.00
CRIS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 203000.00
CRIS income_statement (annual, 2024-12-31) — Research And Development: 38562000.00
CRIS balance_sheet (annual, 2024-12-31) — Retained Earnings: -1239799000.00
CRIS income_statement (annual, 2024-12-31) — Salaries And Wages: 8722000.00
CRIS cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CRIS cash_flow (annual, 2024-12-31) — Sale Of Investment: 47540000.00
CRIS cash_flow (quarterly, 2024-12-31) — Sale Of Investment: -428000.00
CRIS income_statement (annual, 2024-12-31) — Selling General And Administration: 16790000.00
CRIS balance_sheet (annual, 2024-12-31) — Share Issued: 424390.00
CRIS income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CRIS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 5927000.00
CRIS balance_sheet (annual, 2024-12-31) — Stockholders Equity: -5998000.00
CRIS balance_sheet (annual, 2024-12-31) — Tangible Book Value: -14980000.00
CRIS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CRIS balance_sheet (annual, 2024-12-31) — Total Assets: 41265000.00
CRIS balance_sheet (annual, 2024-12-31) — Total Capitalization: -5998000.00
CRIS balance_sheet (annual, 2024-12-31) — Total Debt: 2954000.00
CRIS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: -5998000.00
CRIS income_statement (annual, 2024-12-31) — Total Expenses: 55450000.00
CRIS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 47263000.00
CRIS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 14880000.00
CRIS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 28236000.00
CRIS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -44542000.00
CRIS income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
CRIS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRIS balance_sheet (annual, 2024-12-31) — Working Capital: 7358000.00
CRIS income_statement (quarterly, 2025-03-31) — +Operating Expense: 12523000.00
CRIS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2380000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5104000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2315000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1243703000.00
CRIS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: 0.00
CRIS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 424694.00
CRIS income_statement (quarterly, 2025-03-31) — Basic EPS: -25.00
CRIS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 20541000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 2639000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 105000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 20282000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 20282000.00
CRIS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 7537000.00
CRIS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
CRIS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -7252000.00
CRIS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -315000.00
CRIS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 290000.00
CRIS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 825000.00
CRIS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1034000.00
CRIS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1834000.00
CRIS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1034000.00
CRIS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 285000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Common Stock: 105000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -6607000.00
CRIS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 10000000.00
CRIS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 14000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 5185000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Current Assets: 24811000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1301000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1301000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 20117000.00
CRIS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 59000.00
CRIS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 59000.00
CRIS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 424694.00
CRIS income_statement (quarterly, 2025-03-31) — Diluted EPS: -25.00
CRIS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — EBIT: -10157000.00
CRIS income_statement (quarterly, 2025-03-31) — EBITDA: -10098000.00
CRIS cash_flow (quarterly, 2025-03-31) — End Cash Position: 20826000.00
CRIS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 7537000.00
CRIS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -7252000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CRIS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3984000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Goodwill: 8982000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3029000.00
CRIS income_statement (quarterly, 2025-03-31) — Gross Profit: 2366000.00
CRIS income_statement (quarterly, 2025-03-31) — Insurance And Claims: 205000.00
CRIS income_statement (quarterly, 2025-03-31) — Interest Income: 93000.00
CRIS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 93000.00
CRIS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 453000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Invested Capital: -6607000.00
CRIS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
CRIS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 10000000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1338000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1338000.00
CRIS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 10000000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Income: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -10616000.00
CRIS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -10616000.00
CRIS income_statement (quarterly, 2025-03-31) — Net Interest Income: 93000.00
CRIS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CRIS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 93000.00
CRIS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2463000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3029000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -15589000.00
CRIS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -10098000.00
CRIS income_statement (quarterly, 2025-03-31) — Normalized Income: -10616000.00
CRIS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -7252000.00
CRIS income_statement (quarterly, 2025-03-31) — Operating Income: -10157000.00
CRIS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2380000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 523112.00
CRIS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2214000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 7234000.00
CRIS income_statement (quarterly, 2025-03-31) — Other Gand A: 1895000.00
CRIS income_statement (quarterly, 2025-03-31) — Other Income Expense: -552000.00
CRIS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 307000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2504000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 24478000.00
CRIS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -552000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3029000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Payables: 5104000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10289000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1293000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CRIS income_statement (quarterly, 2025-03-31) — Pretax Income: -10616000.00
CRIS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CRIS balance_sheet (quarterly, 2025-03-31) — Receivables: 2315000.00
CRIS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 14000.00
CRIS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 59000.00
CRIS income_statement (quarterly, 2025-03-31) — Research And Development: 8539000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1250415000.00
CRIS income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1884000.00
CRIS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
CRIS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3984000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Share Issued: 523112.00
CRIS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1164000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: -6607000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -15589000.00
CRIS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Assets: 39326000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: -6607000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2639000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: -6607000.00
CRIS income_statement (quarterly, 2025-03-31) — Total Expenses: 12537000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 45933000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 14515000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 25816000.00
CRIS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -10157000.00
CRIS balance_sheet (quarterly, 2025-03-31) — Working Capital: 4694000.00
CRIS income_statement (quarterly, 2025-06-30) — +Operating Expense: 10984000.00
CRIS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2749000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4097000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 2752000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1244915000.00
CRIS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: 0.00
CRIS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 631382.00
CRIS income_statement (quarterly, 2025-06-30) — Basic EPS: -13.60
CRIS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 20826000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 2309000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 107000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 10138000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 10138000.00
CRIS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -2135000.00
CRIS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 0.00
CRIS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -8009000.00
CRIS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -330000.00
CRIS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -171000.00
CRIS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 29000.00
CRIS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -437000.00
CRIS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -909000.00
CRIS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -437000.00
CRIS cash_flow (quarterly, 2025-06-30) — Changes In Cash: -10144000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Common Stock: 107000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: -13986000.00
CRIS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: -578000.00
CRIS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 16000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 5027000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Current Assets: 14419000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1265000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1265000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 19372000.00
CRIS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 42000.00
CRIS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 42000.00
CRIS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 631382.00
CRIS income_statement (quarterly, 2025-06-30) — Diluted EPS: -13.60
CRIS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — EBIT: -8251000.00
CRIS income_statement (quarterly, 2025-06-30) — EBITDA: -8209000.00
CRIS cash_flow (quarterly, 2025-06-30) — End Cash Position: 10682000.00
CRIS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -2135000.00
CRIS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -8009000.00
CRIS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3526000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Goodwill: 8982000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2673000.00
CRIS income_statement (quarterly, 2025-06-30) — Gross Profit: 2733000.00
CRIS income_statement (quarterly, 2025-06-30) — Insurance And Claims: 209000.00
CRIS income_statement (quarterly, 2025-06-30) — Interest Income: 92000.00
CRIS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 92000.00
CRIS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 349000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Invested Capital: -13986000.00
CRIS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 0.00
CRIS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: -578000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1044000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1044000.00
CRIS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -578000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Income: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -8593000.00
CRIS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -8593000.00
CRIS income_statement (quarterly, 2025-06-30) — Net Interest Income: 92000.00
CRIS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CRIS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 92000.00
CRIS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1557000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Net PPE: 2673000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -22968000.00
CRIS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -8209000.00
CRIS income_statement (quarterly, 2025-06-30) — Normalized Income: -8593000.00
CRIS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -8009000.00
CRIS income_statement (quarterly, 2025-06-30) — Operating Income: -8251000.00
CRIS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2749000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 535419.00
CRIS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1529000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 7353000.00
CRIS income_statement (quarterly, 2025-06-30) — Other Gand A: 1355000.00
CRIS income_statement (quarterly, 2025-06-30) — Other Income Expense: -434000.00
CRIS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 316000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 3160000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 22804000.00
CRIS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -434000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Other Properties: 2673000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Payables: 4097000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 9124000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1630000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRIS income_statement (quarterly, 2025-06-30) — Pretax Income: -8593000.00
CRIS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
CRIS balance_sheet (quarterly, 2025-06-30) — Receivables: 2752000.00
CRIS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 16000.00
CRIS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 42000.00
CRIS income_statement (quarterly, 2025-06-30) — Research And Development: 7458000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1259008000.00
CRIS income_statement (quarterly, 2025-06-30) — Salaries And Wages: 1962000.00
CRIS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CRIS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3526000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Share Issued: 535419.00
CRIS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1135000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -13986000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -22968000.00
CRIS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Assets: 29234000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -13986000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Debt: 2309000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -13986000.00
CRIS income_statement (quarterly, 2025-06-30) — Total Expenses: 11000000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 43220000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 14815000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 23848000.00
CRIS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -8251000.00
CRIS balance_sheet (quarterly, 2025-06-30) — Working Capital: -4953000.00
CRIS income_statement (quarterly, 2025-09-30) — +Operating Expense: 10085000.00
CRIS income_statement (quarterly, 2025-09-30) — +Total Revenue: 3176000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 4445000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3243000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1251919000.00
CRIS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: 0.00
CRIS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 784008.00
CRIS income_statement (quarterly, 2025-09-30) — Basic EPS: -9.80
CRIS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 10682000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1968000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 127000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 9051000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 9051000.00
CRIS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 4482000.00
CRIS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 0.00
CRIS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -5569000.00
CRIS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -341000.00
CRIS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1030000.00
CRIS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 643000.00
CRIS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -491000.00
CRIS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 841000.00
CRIS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -491000.00
CRIS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1087000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Common Stock: 127000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -14691000.00
CRIS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 6049000.00
CRIS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 15000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4768000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Current Assets: 13907000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1228000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1228000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 19912000.00
CRIS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 32000.00
CRIS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 32000.00
CRIS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 784008.00
CRIS income_statement (quarterly, 2025-09-30) — Diluted EPS: -9.80
CRIS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — EBIT: -6924000.00
CRIS income_statement (quarterly, 2025-09-30) — EBITDA: -6892000.00
CRIS cash_flow (quarterly, 2025-09-30) — End Cash Position: 9595000.00
CRIS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 4482000.00
CRIS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -5569000.00
CRIS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3653000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Goodwill: 8982000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2319000.00
CRIS income_statement (quarterly, 2025-09-30) — Gross Profit: 3161000.00
CRIS income_statement (quarterly, 2025-09-30) — Insurance And Claims: 170000.00
CRIS income_statement (quarterly, 2025-09-30) — Interest Income: 80000.00
CRIS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 80000.00
CRIS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 729000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Invested Capital: -14691000.00
CRIS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 0.00
CRIS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 6049000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 740000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 740000.00
CRIS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 6049000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Income: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -7729000.00
CRIS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -7729000.00
CRIS income_statement (quarterly, 2025-09-30) — Net Interest Income: 80000.00
CRIS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CRIS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 80000.00
CRIS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -1567000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2319000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -23673000.00
CRIS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -6892000.00
CRIS income_statement (quarterly, 2025-09-30) — Normalized Income: -7729000.00
CRIS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -5569000.00
CRIS income_statement (quarterly, 2025-09-30) — Operating Income: -6924000.00
CRIS income_statement (quarterly, 2025-09-30) — Operating Revenue: 3176000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 636692.00
CRIS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1613000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 6951000.00
CRIS income_statement (quarterly, 2025-09-30) — Other Gand A: 1676000.00
CRIS income_statement (quarterly, 2025-09-30) — Other Income Expense: -885000.00
CRIS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 363000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 2433000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 21680000.00
CRIS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -885000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2319000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Payables: 4445000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 9213000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 2520000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRIS income_statement (quarterly, 2025-09-30) — Pretax Income: -7729000.00
CRIS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
CRIS balance_sheet (quarterly, 2025-09-30) — Receivables: 3243000.00
CRIS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 15000.00
CRIS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 32000.00
CRIS income_statement (quarterly, 2025-09-30) — Research And Development: 6432000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1266737000.00
CRIS income_statement (quarterly, 2025-09-30) — Salaries And Wages: 1807000.00
CRIS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CRIS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3653000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Share Issued: 636692.00
CRIS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 924000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -14691000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -23673000.00
CRIS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRIS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Assets: 27641000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -14691000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1968000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -14691000.00
CRIS income_statement (quarterly, 2025-09-30) — Total Expenses: 10100000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 42332000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 13734000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 22420000.00
CRIS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -6924000.00
CRIS balance_sheet (quarterly, 2025-09-30) — Working Capital: -6005000.00
CRIS income_statement (annual, 2025-12-31) — +Operating Expense: 42300000.00
CRIS income_statement (quarterly, 2025-12-31) — +Operating Expense: 8708000.00
CRIS income_statement (annual, 2025-12-31) — +Total Revenue: 9443000.00
CRIS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1138000.00
CRIS balance_sheet (annual, 2025-12-31) — Accounts Payable: 5612000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5612000.00
CRIS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 0.00
CRIS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 0.00
CRIS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -851000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -851000.00
CRIS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1252714000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1252714000.00
CRIS cash_flow (annual, 2025-12-31) — Amortization Of Securities: 0.00
CRIS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: 0.00
CRIS income_statement (annual, 2025-12-31) — Basic Average Shares: 658201.00
CRIS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 787353.00
CRIS income_statement (annual, 2025-12-31) — Basic EPS: -11.60
CRIS income_statement (quarterly, 2025-12-31) — Basic EPS: 24.60
CRIS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 20541000.00
CRIS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9595000.00
CRIS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1618000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1618000.00
CRIS balance_sheet (annual, 2025-12-31) — Capital Stock: 129000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 129000.00
CRIS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5061000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5061000.00
CRIS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5061000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5061000.00
CRIS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 9765000.00
CRIS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -119000.00
CRIS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2500000.00
CRIS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2500000.00
CRIS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -27201000.00
CRIS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6371000.00
CRIS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1336000.00
CRIS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -350000.00
CRIS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2546000.00
CRIS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1397000.00
CRIS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1572000.00
CRIS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 75000.00
CRIS cash_flow (annual, 2025-12-31) — Change In Receivables: -1032000.00
CRIS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -1138000.00
CRIS cash_flow (annual, 2025-12-31) — Change In Working Capital: 1750000.00
CRIS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -16000.00
CRIS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1032000.00
CRIS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -1138000.00
CRIS cash_flow (annual, 2025-12-31) — Changes In Cash: -14936000.00
CRIS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3990000.00
CRIS balance_sheet (annual, 2025-12-31) — Common Stock: 129000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Common Stock: 129000.00
CRIS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 5462000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 5462000.00
CRIS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 15352000.00
CRIS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: -119000.00
CRIS income_statement (annual, 2025-12-31) — Cost Of Revenue: 45000.00
CRIS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 0.00
CRIS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 7274000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 7274000.00
CRIS balance_sheet (annual, 2025-12-31) — Current Assets: 6915000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Current Assets: 6915000.00
CRIS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1190000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1190000.00
CRIS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1190000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1190000.00
CRIS balance_sheet (annual, 2025-12-31) — Current Liabilities: 14076000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 14076000.00
CRIS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 169000.00
CRIS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 36000.00
CRIS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 169000.00
CRIS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 36000.00
CRIS income_statement (annual, 2025-12-31) — Diluted Average Shares: 658201.00
CRIS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 787353.00
CRIS income_statement (annual, 2025-12-31) — Diluted EPS: -11.60
CRIS income_statement (quarterly, 2025-12-31) — Diluted EPS: 24.60
CRIS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -7582000.00
CRIS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 19356000.00
CRIS income_statement (annual, 2025-12-31) — EBIT: -5397000.00
CRIS income_statement (quarterly, 2025-12-31) — EBIT: 19935000.00
CRIS income_statement (annual, 2025-12-31) — EBITDA: -5228000.00
CRIS income_statement (quarterly, 2025-12-31) — EBITDA: 19971000.00
CRIS cash_flow (annual, 2025-12-31) — End Cash Position: 5605000.00
CRIS cash_flow (quarterly, 2025-12-31) — End Cash Position: 5605000.00
CRIS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 9765000.00
CRIS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -119000.00
CRIS cash_flow (annual, 2025-12-31) — Free Cash Flow: -27201000.00
CRIS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -6371000.00
CRIS income_statement (annual, 2025-12-31) — General And Administrative Expense: 14046000.00
CRIS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 2883000.00
CRIS balance_sheet (annual, 2025-12-31) — Goodwill: 8982000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Goodwill: 8982000.00
CRIS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 8982000.00
CRIS balance_sheet (annual, 2025-12-31) — Gross PPE: 2803000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 2803000.00
CRIS income_statement (annual, 2025-12-31) — Gross Profit: 9398000.00
CRIS income_statement (quarterly, 2025-12-31) — Gross Profit: 1138000.00
CRIS income_statement (annual, 2025-12-31) — Insurance And Claims: 741000.00
CRIS income_statement (quarterly, 2025-12-31) — Insurance And Claims: 157000.00
CRIS income_statement (annual, 2025-12-31) — Interest Expense: 2185000.00
CRIS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 2185000.00
CRIS income_statement (annual, 2025-12-31) — Interest Income: 316000.00
CRIS income_statement (quarterly, 2025-12-31) — Interest Income: 51000.00
CRIS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 316000.00
CRIS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 51000.00
CRIS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1534000.00
CRIS cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 3000.00
CRIS balance_sheet (annual, 2025-12-31) — Invested Capital: 5462000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 5462000.00
CRIS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 2500000.00
CRIS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 2500000.00
CRIS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 15352000.00
CRIS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: -119000.00
CRIS balance_sheet (annual, 2025-12-31) — Leases: 214000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Leases: 214000.00
CRIS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 428000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 428000.00
CRIS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 428000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 428000.00
CRIS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 699000.00
CRIS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 699000.00
CRIS cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 2500000.00
CRIS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 15352000.00
CRIS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -119000.00